Paranasal sinus squamous cell carcinoma
MONDO:0044705A squamous cell carcinoma that arises from the mucosal epithelial surface of the ethmoid, frontal, maxillary, or sphenoid sinus. Patients may present with nasal fullness, obstruction, and/or epistaxis.
Also known as: epidermoid carcinoma of paranasal sinus, epidermoid carcinoma of the paranasal sinus, paranasal sinus epidermoid carcinoma, paranasal sinus squamous cell carcinoma, squamous cell carcinoma of paranasal sinus, squamous cell carcinoma of the nasal cavity and sinuses, squamous cell carcinoma of the paranasal sinus, squamous cell carcinoma of the nasal cavity and paranasal sinuses
2872 clinical trials for this condition and its sub-types, 11 tagged with Paranasal sinus squamous cell carcinoma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Paranasal sinus squamous cell carcinoma
-
Double-Drug attack shows promise for tough head and neck cancers
Disease control CompletedThis study tested whether combining two FDA-approved cancer drugs, cetuximab and nivolumab, could help people with advanced head and neck cancer that has returned or spread. A total of 95 participants received the drug combination to find the best dose and see if it improves surv…
Phase 1/2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Experimental combo targets Hard-to-Treat head and neck cancers
Disease control CompletedThis early-phase trial tested a combination of two drugs — IRX-2 and durvalumab — in 19 people with advanced head and neck cancer that could not be cured by standard treatments. The goal was to see if the combination was safe and could boost the immune response inside tumors. The…
Phase 1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC